Category: Life Sciences
Quotient Sciences, the drug development and manufacturing accelerator, today announced that it has grown the workforce at its Alnwick, UK, facility by 20% over the past 2 years. The Alnwick site’s growth has been fuelled by its attractive location, variety of career opportunities, and strong people leadership. Quotient Sciences Alnwick currently employs over 200 people […]
Quotient Sciences, the drug development and manufacturing accelerator, has held an official ribbon cutting event in celebration of the grand opening of their new drug substance manufacturing facility in Alnwick, Northumberland. The event hosted by the CEO of SCI (Society of Chemical Industry), Sharon Todd, and Quotient Sciences’ SVP and Head of Candidate Development, Paul […]
Globally SportsTech is booming, with the UK sector also experiencing significant growth thanks to digital adoption in sport alongside immersive tech and artificial intelligence. With its mix of academic expertise, cost-effective accommodation, quality of life, and access to talent, North East England is primed for esports and SportsTech companies looking to expand operations. Specialist facilities […]
A city centre building tailored to the commercialisation of life sciences has reached full capacity. The Biosphere opened its doors just three years ago, and is now home to more than 20 businesses, forming a vibrant and innovative life science cluster on Newcastle Helix. This fit-for-purpose laboratory and office building is dedicated to life science […]
Scientists from leading biotech company ExplantLab in Newcastle (UK) have discovered a genetic link to explain why some patients develop pain and early failure of joint replacements. In what is a world first, the research published by ExplantLab in leading biomedical research journal Nature Communications Medicine (24 June), could transform the way orthopaedic surgery is […]
Pfizer Inc. (NYSE: PFE) and ReViral Ltd. announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel antiviral therapeutics that target respiratory syncytial virus (RSV). Albert Bourla, Chairman and Chief Executive Officer, Pfizer said: “At […]
Following its move to new premises in Newcastle, independent innovation organisation CPI is looking to collaborate and support the commercialisation of deep tech innovations that solve healthcare and sustainability challenges. CPI has moved into The Catalyst building on Newcastle Helix, a ground-breaking 24-acre city centre development that brings together industry leaders, businesses, and top researchers […]
Life sciences talent and strategic consultancy, RBW Consulting, has today announced the opening of a new office in Newcastle city centre which will establish its presence in the North East of England and form part of its wider expansion strategy. RBW Consulting currently has two offices in the UK and a further three in the […]